XHG vs NIVF

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Nov 02, 2026

XHG

33.3
AI Score
VS
XHG Wins

NIVF

26.9
AI Score

Investment Advisor Scores

XHG

33score
Recommendation
EXTENDED

NIVF

27score
Recommendation
AVOID NEW MONEY

AI Analyst Insights

Detailed Metrics Comparison

Metric XHG NIVF Winner
Forward P/E 0 0.0015 Tie
PEG Ratio 0 0 Tie
Revenue Growth 12.6% -4.7% XHG
Earnings Growth 0.0% 0.0% Tie
Tradestie Score 33.3/100 26.9/100 XHG
Profit Margin -22.9% 24.2% NIVF
Beta 1.00 1.00 Tie
AI Recommendation EXTENDED AVOID NEW MONEY XHG

Relative Price Performance (Last 90 Days)

XHG 1M: +76.2% · 3M: -14.2% NIVF 1M: -5.7% · 3M: -52.7%

Current Technical Phase

XHG

Markup
Hold / add on dips

Price above SMA50, rising 50-day trend (3.4% over 20 days), RSI 53

RSI (14): 53.1 · Price: $3.26

NIVF

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 40

RSI (14): 40.1 · Price: $0.28

Fundamentals Snapshot

Metric XHG NIVF
Market Cap — —
Forward P/E 0.0 0.0
Trailing P/E 0.0 —
Revenue (TTM) — —
Revenue Growth 0.1% 0.0%
Gross Margin 0.0% 0.2%
Operating Margin -0.1% -2.4%
EPS 93.92 -37339.45
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, XHG is currently the stronger investment candidate based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.